1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N1486
    Ursonic acid

    熊果酮酸

    Inhibitor 99.88%
    Ursonic acid 是一种天然的三萜酸,具有口服活性。Ursolic acid 可以通过多种信号通路诱发人类癌症细胞的细胞凋亡。Ursolic acid 具有抗炎和抗癌活性。
    Ursonic acid
  • HY-N0513
    Loganic acid

    马钱苷酸

    Inhibitor 99.05%
    Loganic acid 是从山茱萸果实中分离得到的一种环烯醚萜。Loganic acid 抑制 NF-κB 信号通路,激活 Nrf2 信号通路,具有抗炎活性。Loganic acid 能调节饮食引起的动脉粥样硬化和氧化还原状态。Loganic acid 具有很强的自由基清除活性,对重金属介导的毒性有显著的细胞保护作用。Loganic acid 具有口服活性。
    Loganic acid
  • HY-121705
    Propionyl-L-carnitine Inhibitor
    Propionyl-L-carnitine 是一种口服活性的 L-carnitine 衍生物。Propionyl-L-carnitine 对肌肉L-肉碱转移酶具有高亲和力。Propionyl-L-carnitine 可增加凋亡 (Apoptosis)、Bax,并降低 NF-κBVCAM-1MCP-1survivin。Propionyl-L-carnitine 可激活 Src 激酶、Akt,诱导 p-AMPK 和一氧化氮合成 (nitric oxide synthesis)。Propionyl-L-carnitine 可缓解心血管疾病、肥胖症和结肠炎。
    Propionyl-L-carnitine
  • HY-N0747
    Oxypeucedanin

    氧化前胡素

    Inhibitor 99.50%
    Oxypeucedanin 是可在 Angelica dahurica 中发现的呋喃香豆素衍生物。Oxypeucedanin 是一种具有口服活性的 PI3K/AKT/NF-κBMAPKROS 抑制剂。Oxypeucedanin 可诱导细胞周期阻滞和细胞凋亡 (apoptosis)。Oxypeucedanin 可抑制 hKv1.5 通道电流 (IC50: 76 nM)。Oxypeucedanin 具有抗癌、抗炎、抗氧化和抗心律失常活性。
    Oxypeucedanin
  • HY-119459
    Fluopyram

    氟吡菌酰胺

    Activator 99.76%
    Fluopyram 是一种口服活性琥珀酸脱氢酶 (succinate dehydrogenase) 抑制剂,抗真菌剂 (antifungal) 和杀线虫剂。Fluopyram 抑制琥珀酸脱氢酶的活性、激活 CAR/PXR 核受体、增加 caspase-3TNF-αNF-κB。Fluopyram 抑制 F. virguliformeBotrytis cinereaAlternaria solani 的生长,EC50 值分别为 3.35、5.389 和 0.244 µg/mL。Fluopyram 诱导肝脏、甲状腺肿瘤形成。Fluopyram 具有肾脏、胚胎毒性。
    Fluopyram
  • HY-P1633
    Protegrin-1 Activator 99.55%
    Protegrin-1 是一种口服活性抗菌肽。Protegrin-1 激活 ERKCOX2NFκB,抑制凋亡 (Apoptosis)、NO 生成。Protegrin-1 对金黄色葡萄球菌、屎肠球菌、大肠杆菌、铜绿假单胞菌和肺炎克雷伯菌具有抗菌活性,MBC 值在 10 至 20 µM 之间。Protegrin-1 对登革热 NS2B-NS3 具有抗病毒 (antiviral) 活性。Protegrin-1 具有抗炎活性。Protegrin-1 用于炎症性疾病和感染研究。
    Protegrin-1
  • HY-101364A
    CHPG sodium salt Activator 99.25%
    CHPG sodium salt 是一个选择性的 mGluR5 激动剂,并且通过 TSG-6/NF-κB 途径减弱 BV2 小神经胶质细胞 SO2 诱导的氧化应激和炎症。 CHPG sodium salt 通过 ERKAkt 途径在体外和体内预防创伤性脑损伤 (TBI)。
    CHPG sodium salt
  • HY-P9958A
    Denosumab (anti-TNFSF11) Inhibitor 99.9%
    Denosumab (anti-TNFSF11) 是一种靶向 RANKL 蛋白的人单克隆抗体。Denosumab 结合 receptor activator of nuclear factor kappa-B ligand (RANKL) 并阻止其与 RANK 受体结合 (对人 RANKL 的 KD 为 0.003 nM)。Denosumab 促进增殖和精子发生。Denosumab 通过抑制 NF-κB 途径防止骨吸收。Denosumab 可用于骨相关研究。
    Denosumab (anti-TNFSF11)
  • HY-P1847A
    IKKγ NBD Inhibitory Peptide TFA 98.20%
    IKKγ NBD 抑制肽 TFA 是一种高度特异性的 NF-κB 抑制剂。IKKγ NBD 抑制肽 TFA 通过阻断 IKKγ/NEMO 结合域 (NBD) 与 IKKα 和 IKKβ 之间的相互作用,而阻断 TNF-α 诱导的 NF-κB 激活。IKKγ NBD 抑制肽 TFA 可显著降低炎症、改善脑缺血所致的神经功能缺损。
    IKKγ NBD Inhibitory Peptide TFA
  • HY-N6246
    Asperulosidic Acid

    车叶草苷酸

    Inhibitor 99.72%
    Asperulosidic Acid (ASPA) 车叶草苷酸是一种具有生物活性的环烯醚萜苷,从白花蛇舌草 (Hedyotis diffusa Willd) 的草药中提取的。 Asperulosidic Acid (ASPA) 具有抗肿瘤,抗氧化和抗炎作用。 Asperulosidic Acid (ASPA) 通过抑制 NF-κB 和丝裂原活化蛋白激酶 (MAPK) 信号通路抑制炎性细胞因子(TNF-α,IL-6) 释放发挥抗炎作用。
    Asperulosidic Acid
  • HY-N2491
    Deoxyelephantopin

    去氧地胆草素

    Inhibitor 99.87%
    Deoxyelephantopin 是一种来自 Elephantopus scaber 的,具有生物活性的天然倍半萜烯内酯。可广泛用于癌症方面的研究。Deoxyelephantopin 抑制 NF-κBMAPKPI3K/Aktβ-catenin 信号传导。
    Deoxyelephantopin
  • HY-N0713
    Diosmetin-7-O-β-D-glucopyranoside

    香叶木素-7-O-葡萄糖苷,

    99.61%
    Diosmetin-7-O-β-D-glucopyranoside 是一种天然产物,可从菊花中分离得到。Diosmetin-7-O-β-D-glucopyranoside 在体外 (IC50 = 0.74 μM) 和体内实验中均表现出强效的抗 SARS-CoV-2 抗病毒和抗炎活性。Diosmetin-7-O-β-D-glucopyranoside 在斑马鱼模型中,与芫荽 (Pae) 和5-羟甲基糠醛 (5-HMF) 以 3:4:3的比例结合时,具有显著的抗血栓活性。
    Diosmetin-7-O-β-D-glucopyranoside
  • HY-153368
    Zomiradomide Inhibitor
    Zomiradomide 是一种口服有效的 PROTAC 降解剂,可降解IRAK4DC50=6 nM),从而抑制 NF-κB 信号通路。Zomiradomide 还可作为分子胶,募集 Ikaros 和 Aiolos 并介导其降解(Ikaros 的DC50为1 nM),从而激活 I 型干扰素信号通路。(Pink: target protein ligand PROTAC IRAK4 ligand-5 (HY-168311), Blue: E3 ligase ligand Thalidomide-4-Br (HY-W039116), Black: linker (HY-168313))
    Zomiradomide
  • HY-N2481
    Oroxylin A-7-O-glucuronide Inhibitor 99.83%
    Oroxylin A-7-O-glucuronide (Oroxyloside) 是一种口服活性的类黄酮葡糖苷酸和 Oroxylin A (HY-N0560) 的代谢产物。Oroxylin A-7-O-glucuronide 可从 Scutellaria baicalensis 干燥的根中提取。Oroxylin A-7-O-glucuronide 具有脯氨酰寡肽酶抑制作用。Oroxylin A-7-O-glucuronide 抑制 JNK 通路, 上调 PPARγ 并抑制 NF-κB p65 核易位。Oroxylin A-7-O-glucuronide 减少细胞因子 (IL-1βIL-6)。Oroxylin A-7-O-glucuronide 具有抗血管生成、抗肿瘤 (胶质瘤、肝癌)、抗炎、肝保护作用。
    Oroxylin A-7-O-glucuronide
  • HY-N6051
    (-​)​-Maackiain

    高丽槐素

    Inhibitor 99.91%
    (-)-Maackiain 是由Sophora flavescens 产生的紫檀素类植物抗毒素。(-)-Maackiain 对豆科植物和非豆科植物宿主的几种真菌病原体有毒。(-)-Maackiain 可增强 NLRP3 炎症小体的活化,抑制 NF-κB 通路的活化,从而发挥免疫刺激和抗炎活性。(-)-Maackiain 具有口服活性。
    (-​)​-Maackiain
  • HY-N0257
    Epimedin A

    朝藿定A

    Inhibitor 99.43%
    Epimedin A 是淫羊藿 (Herba Epimedii) 中主要的黄酮类活性成分之一,具有口服活性。Epimedin A 可抑制破骨细胞生成、分化和骨吸收。Epimedin A 具有抗炎活性。Epimedin A 可用于骨质疏松和炎症性疾病的研究。
    Epimedin A
  • HY-16561A
    cis-Resveratrol

    顺式白藜芦醇

    Inhibitor 98.83%
    cis-Resveratrol 具有显着的抗病毒活性。cis-Resveratrol 抑制肠道病毒,对 CVB3 和 EV71 的 IC50 分别为 12.2 µM 和 37.6 µM。cis-Resveratrol 是 NF-κB 信号通路的抑制剂。
    cis-Resveratrol
  • HY-147972
    NF-κB/MAPK-IN-1 Inhibitor 98.71%
    NF-κB/MAPK-IN-1 (compound 11a) 是一种有效的 NF-κBMAPK 通路抑制剂。NF-κB/MAPK-IN-1 对 NO 生成具有抑制作用,其 IC50 为6.96 μM。NF-κB/MAPK-IN-抑制 LPS 诱导的 iNOSCOX-2ERΚP38 激活。 NF-κB/MAPK-IN-1 可抑制 LPS 诱导的巨噬细胞炎症反应。 NF-κB/MAPK-IN-1 可用于类风湿关节炎 (RA) 的研究。
    NF-κB/MAPK-IN-1
  • HY-N6588
    3,4,5-Tricaffeoylquinic acid

    3,4,5-三咖啡酰奎宁酸

    Inhibitor 98.71%
    3,4,5-Tricaffeoylquinic acid (3,4,5-triCQA) 通过抑制 AktNF-κB 途径抑制肿瘤坏死因子-α 刺激角质形成细胞中炎性介质的产生。3,4,5-Tricaffeoylquinic acid 诱导人神经干细胞 G0/G1 细胞周期阻滞、肌动蛋白骨架组织、染色质重塑、神经元分化和骨形态发生蛋白信号传导。3,4,5-Tricaffeoylquinic acid 在衰老相关疾病的研究中具有潜在的应用前景。
    3,4,5-Tricaffeoylquinic acid
  • HY-N7688
    Regaloside B

    王百合苷 B

    Inhibitor 99.90%
    Regaloside B 是一种苯丙烷。Regaloside B 可从 Lilium longiflorum 中分离出来。Regaloside B 可以抑制 VCAM-1iNOSCOX-2 的表达,p-p65/p-65 比例。Regaloside B 抑制多种趋化因子和血管生成因子 mRNA (CXCL9CXCL10IL8IDO)。Regaloside B 具有抗炎活性。Regaloside B 可用于成骨分化研究。
    Regaloside B
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.